These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27480580)

  • 1. Stealth Engineering for In Vivo Drug Delivery Systems.
    Mohapatra A; Morshed BI; Haggard WO; Smith RA
    Crit Rev Biomed Eng; 2015; 43(5-6):347-69. PubMed ID: 27480580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging].
    Kawakami S; Suga T
    Yakugaku Zasshi; 2020; 140(5):633-640. PubMed ID: 32378663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of 'intelligent' liposomes for efficient delivery of drugs.
    Voinea M; Simionescu M
    J Cell Mol Med; 2002; 6(4):465-74. PubMed ID: 12611636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug transport kinetics of intravascular triggered drug delivery systems.
    Ten Hagen TLM; Dreher MR; Zalba S; Seynhaeve ALB; Amin M; Li L; Haemmerich D
    Commun Biol; 2021 Jul; 4(1):920. PubMed ID: 34321602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
    Oku N
    Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive Molecule-loaded Drug Delivery Systems to Optimize Bone Tissue Repair.
    Oshiro JA; Sato MR; Scardueli CR; Lopes de Oliveira GJP; Abucafy MP; Chorilli M
    Curr Protein Pept Sci; 2017; 18(8):850-863. PubMed ID: 28355998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
    Ahmed SE; Martins AM; Husseini GA
    J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitochondrial DDS Opens Innovative Pharmaceutics].
    Yamada Y
    Yakugaku Zasshi; 2016; 136(1):55-62. PubMed ID: 26725668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
    Kuang H; Ku SH; Kokkoli E
    Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design attributes of long-circulating polymeric drug delivery vehicles.
    Beck-Broichsitter M; Nicolas J; Couvreur P
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):304-17. PubMed ID: 25857838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Screening System for Targeting Carriers Using Peptide-Modified Liposomes and Tissue Sections.
    Negishi Y; Hamano N; Sato H; Katagiri F; Takatori K; Endo-Takahashi Y; Kikkawa Y; Nomizu M
    Biol Pharm Bull; 2018; 41(7):1107-1111. PubMed ID: 29962407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal systems for tumor targeting.
    Storm G; Crommelin DJ
    Hybridoma; 1997 Feb; 16(1):119-25. PubMed ID: 9085138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of intelligent DDS technologies].
    Okano T
    Nihon Rinsho; 1993 Nov; 51(11):3042-50. PubMed ID: 8277588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier-based strategies for targeting protein and peptide drugs to the lungs.
    Cryan SA
    AAPS J; 2005 Mar; 7(1):E20-41. PubMed ID: 16146340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.